Pfizer CEO Discusses Impact of Trump’s Pharmaceutical Tariffs
Pfizer CEO Albert Bourla voiced concerns on Tuesday about the uncertainty surrounding President Donald Trump’s planned pharmaceutical tariffs, which are deterring the company from increasing investments in U.S. manufacturing and research and